High Content Screening Market Size, Share, Trends | Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled “High Content Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global high content screening market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the high content screening market?

The global high content screening market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.4% during 2023-2028.

What is high content screening?

High-content screening (HCS) refers to an analytical approach of automated microscopy that relies on visualization tools to collect quantitative data from cell populations. It is a combination of modern cell biology, flow cytometry, and robotic handling that includes fluorescence imaging to identify the physical and biochemical properties of sample cells. It is extensively used in drug discovery and biological research to identify molecules, such as peptides or RNA interference (RNAi), which can change the phenotype of a cell in the desired manner.

Request for a free sample copy of this report: https://www.imarcgroup.com/high-content-screening-market/requestsample

What are the growth prospects and trends in the high content screeningindustry?

The growing prevalence of chronic and neurodegenerative disorders, such as Parkinson’s and Alzheimer’s, is catalyzing the need for affordable and effective drug discovery systems. This, in turn, is positively influencing the market. Apart from this, the escalating demand for cost-effective drug discovery systems in the pharmaceutical industry is strengthening the market growth. Moreover, leading manufacturers are focusing on the development of innovative and technologically advanced equipment integrated with artificial intelligence (AI) systems, which is projected to fuel the market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

• Instruments
• Cell Imaging and Analysis Systems
• Flow Cytometers
• Consumables
• Reagents & Assay Kits
• Microplates
• Other Consumables
• Software
• Services
• Accessories

Breakup by Application:

• Target Identification and Validation
• Primary Screening and Secondary Screening
• Toxicity Studies
• Compound Profiling
• Other Applications

Breakup by End-User:

• Pharmaceutical and Biotechnology Companies
• Academic and Government Institutes
• Contract Research Organizations (CROs)

Breakup by Region:

• North America (U.S. & Canada)
• Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
• Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
• Latin America (Brazil, Mexico)
• Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Becton
• Dickinson and Company
• Bio-Rad Laboratories Inc.
• Biotek Instruments Inc.
• Danaher Corporation
• GE Healthcare,
• Merck Millipore
• Perkinelmer Inc.
• Tecan Group Ltd.
• Thermo Fisher Scientific
• Yokogawa Electric Corporation

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/high-content-screening-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/